Alice Melão, MSc,  —

Articles by Alice Melao

Corbus Pharmaceuticals Expands Its Portfolio With Hundreds of Potential New Agents from Jenrin Discovery

Corbus Pharmaceuticals has acquired from Jenrin Discovery more than 600 compounds designed to target the endocannabinoid system, including CRB-4001 for the treatment of fibrotic diseases affecting the lungs, liver, heart, and kidney. The endocannabinoid system is associated with the resolution (or shutting off) of the inflammatory response, which…